Clinical Trial: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Multi-Center, Randomized, Double-Masked, Placebo-Controlled Evaluation of the Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens as Compared to Placebo in the Prevention of Allergic

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

Detailed Summary:
Sponsor: Vistakon Pharmaceuticals

Current Primary Outcome: Ocular itching

Original Primary Outcome: Same as current

Current Secondary Outcome: Conjunctival, ciliary, and episcleral redness; chemosis and mucous discharge; tearing and lid swelling

Original Secondary Outcome: Same as current

Information By: Vistakon Pharmaceuticals

Dates:
Date Received: February 4, 2007
Date Started: January 2007
Date Completion:
Last Updated: April 8, 2009
Last Verified: April 2009